Sol Langermann

Insider Reports History

Entity
Individual
Location
C/O Nextcure, Inc., 9000 Virginia Manor Road, Suite 200, Beltsville, MD
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Sol Langermann
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sol Langermann:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NextCure, Inc. Chief Scientific Officer Employee Stock Option (Right to Buy) 93.9K Mar 29, 2024 Direct

Insider Reports Filed by Sol Langermann

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NXTC NextCure, Inc. Mar 29, 2024 1 $0 4 Apr 2, 2024 Chief Scientific Officer
NXTC NextCure, Inc. Jan 31, 2024 1 $0 4 Feb 1, 2024 Chief Scientific Officer
NXTC NextCure, Inc. Feb 28, 2023 1 $0 4 Mar 1, 2023 Chief Scientific Officer
NXTC NextCure, Inc. Jan 31, 2022 1 $0 4 Feb 2, 2022 Chief Scientific Officer